Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors
Maurizio S. Riga, Laia Lladó-Pelfort, Francesc Artigas, et al.
Neuropharmacology (2017) Vol. 142, pp. 219-230
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 177
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 161
The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)
Johannes T. Reckweg, Malin V. Uthaug, Attila Szabó, et al.
Journal of Neurochemistry (2022) Vol. 162, Iss. 1, pp. 128-146
Open Access | Times Cited: 59
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
Criticality supports cross-frequency cortical-thalamic information transfer during conscious states
Daniel Toker, Eli J. Műller, Hiroyuki Miyamoto, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 9
Psychedelics as a novel approach to treating autoimmune conditions
Caitlin Thompson, Attila Szabó
Immunology Letters (2020) Vol. 228, pp. 45-54
Open Access | Times Cited: 63
A narrative synthesis of research with 5-MeO-DMT
Anna O. Ermakova, Fiona Dunbar, James Rucker, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 3, pp. 273-294
Open Access | Times Cited: 48
Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology
Rebecca Smausz, Joanna C. Neill, John Gigg
Journal of Psychopharmacology (2022) Vol. 36, Iss. 7, pp. 781-793
Open Access | Times Cited: 33
Thalamic deep brain stimulation paradigm to reduce consciousness: Cortico-striatal dynamics implicated in mechanisms of consciousness
Michelle J. Redinbaugh, Mohsen Afrasiabi, Jessica M. Phillips, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 7, pp. e1010294-e1010294
Open Access | Times Cited: 29
The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics
Marco Onofrj, Mirella Russo, Stefano Delli Pizzi, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action
Stephan C. Tap
Addiction Biology (2024) Vol. 29, Iss. 4
Open Access | Times Cited: 5
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
Hewa Artin, Sidney Zisook, Dhakshin Ramanathan
World Journal of Psychiatry (2021) Vol. 11, Iss. 6, pp. 201-214
Open Access | Times Cited: 28
Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice
Christopher W. Thomas, Cristina Blanco‐Duque, Benjamin J. B. Bréant, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
An introduction to psychedelic neuroscience
Tanya Calvey, Fleur M. Howells
Progress in brain research (2018), pp. 1-23
Closed Access | Times Cited: 37
Serotonin 5-HT1A, 5-HT2A and dopamine D2 receptors strongly influence prefronto-hippocampal neural networks in alert mice: Contribution to the actions of risperidone
Thomas Gener, Adrià Tauste Campo, Maria Alemany-González, et al.
Neuropharmacology (2019) Vol. 158, pp. 107743-107743
Open Access | Times Cited: 32
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
Giordano Novak Rossi, Lorena T. L. Guerra, Glen B. Baker, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1618-1618
Open Access | Times Cited: 17
Paradoxical pharmacological dissociations result from drugs that enhance delta oscillations but preserve consciousness
Joel Frohlich, Pedro A. M. Mediano, Francesco Bavato, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants
James Rucker, Claire Roberts, Mathieu Seynaeve, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 712-723
Closed Access | Times Cited: 3
Distinct 5-HT receptor subtypes regulate claustrum excitability by serotonin and the psychedelic, DOI
Tanner L. Anderson, Jack Keady, Judy C. Songrady, et al.
Progress in Neurobiology (2024) Vol. 240, pp. 102660-102660
Closed Access | Times Cited: 3
A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder
Joseph P. Barsuglia, Martín Polanco, Robert L. Palmer, et al.
Progress in brain research (2018), pp. 121-158
Closed Access | Times Cited: 30
Serotonergic Psychedelics in Neural Plasticity
Kacper Łukasiewicz, Jacob J. Baker, Yi Zuo, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 21
The renaissance in psychedelic research: What do preclinical models have to offer
Kevin S. Murnane
Progress in brain research (2018), pp. 25-67
Closed Access | Times Cited: 24
Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice
Margareth Nogueira, Daiane C Ferreira Golbert, Richardson Menezes, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 2
Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience
Francisco Madrid-Gambín, Àlex Gomez‐Gómez, Arnau Busquets‐Garcia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112845-112845
Open Access | Times Cited: 11
THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways
Hanna J. Szkudlarek, Mar Rodríguez-Ruiz, Roger Hudson, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110029-110029
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top